CN102159623A - 用于人医药和/或医学技术的可生物降解和/或可吸收性硅凝胶材料的生产中的含有至少一种治疗活性成分的硅溶胶材料 - Google Patents

用于人医药和/或医学技术的可生物降解和/或可吸收性硅凝胶材料的生产中的含有至少一种治疗活性成分的硅溶胶材料 Download PDF

Info

Publication number
CN102159623A
CN102159623A CN2009801361358A CN200980136135A CN102159623A CN 102159623 A CN102159623 A CN 102159623A CN 2009801361358 A CN2009801361358 A CN 2009801361358A CN 200980136135 A CN200980136135 A CN 200980136135A CN 102159623 A CN102159623 A CN 102159623A
Authority
CN
China
Prior art keywords
under
cells
hours
reaction
biodegradable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2009801361358A
Other languages
English (en)
Chinese (zh)
Inventor
I.贝克尔
M.罗滕布格尔格劳比特
J.普罗布斯特
H.埃格尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangsu Xinlikang Medical Technology Co ltd
Suzhou Xin Li Kang Pharmaceutical Technology Co ltd
Original Assignee
Bayer Innovation GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Innovation GmbH filed Critical Bayer Innovation GmbH
Publication of CN102159623A publication Critical patent/CN102159623A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/64—Use of materials characterised by their function or physical properties specially adapted to be resorbable inside the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B35/00—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
    • C04B35/622—Forming processes; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
    • C04B35/62227—Forming processes; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products obtaining fibres
    • C04B35/62231—Forming processes; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products obtaining fibres based on oxide ceramics
    • C04B35/6224—Fibres based on silica
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G77/00—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
    • C08G77/04—Polysiloxanes
    • C08G77/06—Preparatory processes
    • C—CHEMISTRY; METALLURGY
    • C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2235/00—Aspects relating to ceramic starting mixtures or sintered ceramic products
    • C04B2235/02—Composition of constituents of the starting material or of secondary phases of the final product
    • C04B2235/30—Constituents and secondary phases not being of a fibrous nature
    • C04B2235/40—Metallic constituents or additives not added as binding phase
    • C04B2235/408—Noble metals
    • C—CHEMISTRY; METALLURGY
    • C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2235/00—Aspects relating to ceramic starting mixtures or sintered ceramic products
    • C04B2235/02—Composition of constituents of the starting material or of secondary phases of the final product
    • C04B2235/30—Constituents and secondary phases not being of a fibrous nature
    • C04B2235/44—Metal salt constituents or additives chosen for the nature of the anions, e.g. hydrides or acetylacetonate
    • C04B2235/441—Alkoxides, e.g. methoxide, tert-butoxide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Organic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Manufacturing & Machinery (AREA)
  • Ceramic Engineering (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Structural Engineering (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Immunology (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Silicon Polymers (AREA)
  • Inorganic Fibers (AREA)
  • Silicon Compounds (AREA)
CN2009801361358A 2008-07-16 2009-07-03 用于人医药和/或医学技术的可生物降解和/或可吸收性硅凝胶材料的生产中的含有至少一种治疗活性成分的硅溶胶材料 Pending CN102159623A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102008033327A DE102008033327A1 (de) 2008-07-16 2008-07-16 Kieselsol-Material mit mindestens einem therapeutisch aktiven Wirkstoff zur Herstellung von biologisch degradierbaren und/oder resorbierbaren Kieselgel-Materialien für die Humanmedizin und/oder Medizintechnik
DE102008033327.1 2008-07-16
PCT/EP2009/004806 WO2010006708A1 (de) 2008-07-16 2009-07-03 Kieselsol-material mit mindestens einem therapeutisch aktiven wirkstoff zur herstellung von biologisch degradierbaren und/oder resorbierbaren kieselgel-materialen für die humanmedizin und/oder medizintechnik

Publications (1)

Publication Number Publication Date
CN102159623A true CN102159623A (zh) 2011-08-17

Family

ID=41011815

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009801361358A Pending CN102159623A (zh) 2008-07-16 2009-07-03 用于人医药和/或医学技术的可生物降解和/或可吸收性硅凝胶材料的生产中的含有至少一种治疗活性成分的硅溶胶材料

Country Status (13)

Country Link
US (1) US20110123596A1 (cg-RX-API-DMAC7.html)
EP (1) EP2303948B1 (cg-RX-API-DMAC7.html)
JP (1) JP2011527913A (cg-RX-API-DMAC7.html)
KR (1) KR20110039533A (cg-RX-API-DMAC7.html)
CN (1) CN102159623A (cg-RX-API-DMAC7.html)
AU (1) AU2009270515A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0915946A2 (cg-RX-API-DMAC7.html)
CA (1) CA2730697C (cg-RX-API-DMAC7.html)
DE (1) DE102008033327A1 (cg-RX-API-DMAC7.html)
IL (1) IL210313A0 (cg-RX-API-DMAC7.html)
MX (1) MX2011000475A (cg-RX-API-DMAC7.html)
RU (1) RU2512512C2 (cg-RX-API-DMAC7.html)
WO (1) WO2010006708A1 (cg-RX-API-DMAC7.html)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108283707A (zh) * 2018-04-05 2018-07-17 广西中医药大学 一种瑶药退烧贴及其制备方法
CN111278474A (zh) * 2017-10-26 2020-06-12 科德宝两合公司 用于引入人体的生物相容性复合材料
CN113332488A (zh) * 2021-05-31 2021-09-03 南昌智产科技有限公司 一种医用硅凝胶泡沫敷料及其制备方法
CN114404660A (zh) * 2022-01-21 2022-04-29 江苏信立康医疗科技有限公司 一种基于三维支架的细胞培养方法
CN115531592A (zh) * 2022-10-27 2022-12-30 李升红 一种实现皮肤高效修复的皮肤敷料及其制备方法

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102010008982A1 (de) * 2010-02-24 2011-08-25 Bayer Innovation GmbH, 40225 Siliciumhaltiges, biologisch degradierbares Material zur anti-inflammatorischen Therapie
DE102010008981A1 (de) * 2010-02-24 2011-08-25 Bayer Innovation GmbH, 40225 Siliciumhaltiges, biologisch degradierbares Material zur pro-angiogenetischen Therapie
DE102010023336A1 (de) * 2010-06-10 2011-12-15 Bayer Innovation Gmbh Verfahren zur Herstellung eines Kieselsol-Materials
MX382405B (es) 2010-07-02 2025-03-13 Procter & Gamble Método para suministrar un agente activo.
EP3533908B1 (en) 2010-07-02 2026-07-01 The Procter & Gamble Company NONWOVEN FABRIC COMPRISING ONE OR MORE ACTIVE AGENTS
JP5859526B2 (ja) 2010-07-02 2016-02-10 ザ プロクター アンド ギャンブルカンパニー 活性剤不織布ウェブを含むフィラメント及びその製造方法
US20180163325A1 (en) 2016-12-09 2018-06-14 Robert Wayne Glenn, Jr. Dissolvable fibrous web structure article comprising active agents
BR112012033600A2 (pt) * 2010-07-02 2016-11-29 Procter & Gamble Comapny filamentos compreendendo mantas de não-tecido com agente ingerível e métodos de fabricação dos mesmos.
US20140065221A1 (en) * 2011-03-31 2014-03-06 Galderma Research & Development Compositions comprising a filler product and at least one bioresorbable and biodegradable silica-based material
FI20155779A7 (fi) * 2015-10-30 2017-05-01 Solani Therapeutics Ltd Ei-steroidaalisen anti-inflammatorisen lääkkeen hidastetusti vapautuva annostelu
CN110191700A (zh) 2017-01-27 2019-08-30 宝洁公司 可溶性固体结构形式的组合物
CN110167639B (zh) 2017-01-27 2022-10-14 宝洁公司 呈包含泡腾型附聚颗粒的可溶性固体结构形式的组合物
JP6923673B2 (ja) 2017-05-16 2021-08-25 ザ プロクター アンド ギャンブル カンパニーThe Procter & Gamble Company 溶解性固形構造体の形態のコンディショニングヘアケア組成物
US20190255223A1 (en) * 2018-02-16 2019-08-22 American Nano, LLC Silica fiber compositions and methods of use
US11666514B2 (en) 2018-09-21 2023-06-06 The Procter & Gamble Company Fibrous structures containing polymer matrix particles with perfume ingredients
JP7381613B2 (ja) 2019-06-28 2023-11-15 ザ プロクター アンド ギャンブル カンパニー アニオン性界面活性剤を含有する溶解性固体繊維性物品
WO2022027067A1 (en) 2020-07-31 2022-02-03 The Procter & Gamble Company Water-soluble fibrous pouch containing prills for hair care
EP4395730A1 (en) 2021-08-30 2024-07-10 The Procter & Gamble Company Dissolvable solid structure comprising first and second polymeric structurants
US12576013B2 (en) 2021-12-17 2026-03-17 The Procter & Gamble Company Dissolvable solid fibrous shampoo articles containing salts
US12540238B2 (en) 2022-03-10 2026-02-03 The Procter & Gamble Company Dissolvable solid structure having first and second layers
DE102023208022A1 (de) * 2023-08-22 2025-02-27 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung eingetragener Verein Kieselsäure freisetzende faser oder faserfragmente, hieraus hergestellte faservliese sowie formulierung
DE102024209914A1 (de) 2024-10-11 2026-04-16 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung eingetragener Verein Lösung zur Herstellung einer bioabbaubaren Beschichtung, Verfahren zu ihrer Herstellung, Verfahren zur Beschichtung eines Substrates sowie damit hergestellter beschichteter Gegenstand

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1262542A2 (de) * 2001-05-29 2002-12-04 Axel Dr. Thierauf Verfahren zur Herstellung von Zellen, Geweben und Organen
DE60035672T2 (de) * 1999-02-22 2008-04-30 Delsitech Oy Biologisch abbaubare silicafasern aus einem silicasol

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19609551C1 (de) 1996-03-12 1997-07-17 Fraunhofer Ges Forschung Biologisch degradierbare und/oder biologisch resorbierbare (Endlos)Fasern, Verfahren zu deren Herstellung und deren Verwendung als Verstärkungsfasern
US6764690B2 (en) * 1996-05-29 2004-07-20 Delsitech Oy Dissolvable oxides for biological applications
NZ332968A (en) * 1996-05-29 2000-08-25 Bioxid Oy A controllably dissolvable silica-xerogel prepared via sol-gel
CA2328614C (en) * 1999-02-12 2012-06-26 Biostream, Inc. Matrices for drug delivery and methods for making and using the same
US7118921B1 (en) * 1999-06-24 2006-10-10 Mcmaster University Incorporation and applications of biomolecular interactions within a carrier
CA2377560C (en) * 1999-06-24 2010-08-24 Mcmaster University Incorporation and applications of biomolecular interactions within a carrier
DE102004063599B4 (de) 2004-12-30 2007-07-12 Bayer Innovation Gmbh Verkürzte Wundheilungsprozesse mittels neuartiger Faservliese
DE102007061873B4 (de) * 2007-01-15 2025-06-26 Bayer Intellectual Property Gmbh Kieselsol-Material zur Herstellung von biologisch degradierbaren und/oder resorbierbaren Kieselgel-Materialien, dessen Herstellung und Verwendung
EP2111417B1 (de) * 2007-01-16 2011-11-30 Basf Se Verfahren zur herstellung von polymerpartikeln durch polymerisation von flüssigkeitstropfen in einer gasphase

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60035672T2 (de) * 1999-02-22 2008-04-30 Delsitech Oy Biologisch abbaubare silicafasern aus einem silicasol
EP1262542A2 (de) * 2001-05-29 2002-12-04 Axel Dr. Thierauf Verfahren zur Herstellung von Zellen, Geweben und Organen

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111278474A (zh) * 2017-10-26 2020-06-12 科德宝两合公司 用于引入人体的生物相容性复合材料
CN108283707A (zh) * 2018-04-05 2018-07-17 广西中医药大学 一种瑶药退烧贴及其制备方法
CN113332488A (zh) * 2021-05-31 2021-09-03 南昌智产科技有限公司 一种医用硅凝胶泡沫敷料及其制备方法
CN114404660A (zh) * 2022-01-21 2022-04-29 江苏信立康医疗科技有限公司 一种基于三维支架的细胞培养方法
CN115531592A (zh) * 2022-10-27 2022-12-30 李升红 一种实现皮肤高效修复的皮肤敷料及其制备方法

Also Published As

Publication number Publication date
DE102008033327A1 (de) 2010-01-21
RU2011105299A (ru) 2012-08-27
WO2010006708A1 (de) 2010-01-21
US20110123596A1 (en) 2011-05-26
IL210313A0 (en) 2011-03-31
BRPI0915946A2 (pt) 2019-04-09
CA2730697A1 (en) 2010-01-21
EP2303948B1 (de) 2018-09-12
CA2730697C (en) 2016-10-25
RU2512512C2 (ru) 2014-04-10
MX2011000475A (es) 2011-03-15
AU2009270515A1 (en) 2010-01-21
JP2011527913A (ja) 2011-11-10
KR20110039533A (ko) 2011-04-19
EP2303948A1 (de) 2011-04-06

Similar Documents

Publication Publication Date Title
CA2730697C (en) Silica sol material having at least one therapeutically active substance for producing biologically degradable and/or resorbable silica gel materials for human medicine and/or medical technology
RU2602620C2 (ru) Кремниевый золь и клеточный комплекс, ткань и/или орган с волокнистой матрицей из поликремниевой кислоты
Salim et al. Influence of chitosan and hydroxyapatite incorporation on properties of electrospun PVA/HA nanofibrous mats for bone tissue regeneration: Nanofibers optimization and in-vitro assessment
Zhang et al. A novel nanosilver/nanosilica hydrogel for bone regeneration in infected bone defects
KR101101321B1 (ko) 상처 치유를 위한 하이드로 겔 형태의 세포전달용 비히클 및 그 제조방법
Datta et al. Oleoyl-chitosan-based nanofiber mats impregnated with amniotic membrane derived stem cells for accelerated full-thickness excisional wound healing
JP2013081783A (ja) カスタマイズされた組成物およびその使用
CN107185025A (zh) 一种中药纳米纺丝复合纤维膜敷料、制备方法及其应用
Keshavarz et al. Using biomaterials to improve mesenchymal stem cell therapies for chronic, nonhealing wounds
Zhu et al. Chondroitin sulfate sponge scaffold for slow-release Mg2+/Cu2+ in diabetic wound management: hemostasis, effusion absorption, and healing
Lu et al. Janus sponge/electrospun fibre composite combined with EGF/bFGF/CHX promotes reconstruction in oral tissue regeneration
CN119524185A (zh) 一种促进创面愈合的纤维类敷料及其制备方法和应用
Guo et al. An injectable, self-healing, anti-infective, and anti-inflammatory novel glycyrrhizic acid hydrogel for promoting acute wound healing and regeneration
Luo et al. Biomimetic tussah silk/chitosan composite scaffolds with radial pore architecture for enhanced wound repair
Wen et al. Multifunctional nanofiber membranes constructed by microfluidic blow-spinning to inhibit scar formation at early intervention stage
WO2020180202A1 (ru) Композиция на основе наночастиц диоксида церия и полисахаридов бурых водорослей для лечения ран
CN116983466A (zh) 一种医用凝胶敷料及其制备方法和应用
CN113827768B (zh) 一种载溶血磷脂酸纳米颗粒的仿生支架的制备方法
CN119950987A (zh) 吸附外泌体的多功能mof微针贴片制备方法及其应用
Nie et al. Schiff base formed functional hydrogel dressing via ϵ-poly-L-lysine modified chitosan and oxidized dextran with the incorporation of epigallocatechin-3-gallate
EP3799891A1 (en) 3d-patterned fiber material for the topical delivery of nucleic acid and the process for its preparation
Çakmen et al. Fabrication and characterization of high molecular mass tmpe-based polyurethane wound dressing materials containing allantoin and gentamicin by electrospinning
Bhattacharya et al. Bioceramics and Bioactive Glasses for Skin Wound Healing
JP2025525354A (ja) 医療用組成物
CN116098855A (zh) 一种含有Cu@ZIF-8粒子的光交联微针及其制备方法与应用

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: JIANGSU XINLIKANG MEDICAL TECHNOLOGY CO., LTD.

Free format text: FORMER OWNER: SUZHOU XINLIKANG PHARMACEUTICAL TECHNOLOGY CO., LTD.

Effective date: 20150813

Owner name: SUZHOU XINLIKANG PHARMACEUTICAL TECHNOLOGY CO., LT

Free format text: FORMER OWNER: BAYER INNOVATION GMBH

Effective date: 20150813

C41 Transfer of patent application or patent right or utility model
C53 Correction of patent of invention or patent application
CB02 Change of applicant information

Address after: Germany Leverkusen

Applicant after: BAYER INNOVATION GmbH

Address before: Dusseldorf

Applicant before: Bayer Innovation GmbH

COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM:

TA01 Transfer of patent application right

Effective date of registration: 20150813

Address after: 225300 Jiangsu city of Taizhou province Chinese pharmaceutical Road No. 50 west of G60 City

Applicant after: Jiangsu Xinlikang Medical Technology Co.,Ltd.

Address before: 112, room 2, building 215021, Lu Xu village, Suzhou, Suzhou Industrial Zone, Jiangsu, China

Applicant before: Suzhou Xin Li Kang Pharmaceutical Technology Co.,Ltd.

Effective date of registration: 20150813

Address after: 112, room 2, building 215021, Lu Xu village, Suzhou, Suzhou Industrial Zone, Jiangsu, China

Applicant after: Suzhou Xin Li Kang Pharmaceutical Technology Co.,Ltd.

Address before: Germany Leverkusen

Applicant before: Bayer Innovation GmbH

C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20110817